Peripheral neuropathies under Immune Checkpoint Inhibitors: A pharmacovigilance study

被引：0
|
作者：
Ewig, E. [1 ]
Fournier, D. [1 ]
Palassin, P. [2 ]
Cholle, C. [3 ]
Bihan, B. [1 ]
Lebrun-Vignes, B. [1 ]
机构：
[1] GH Sorbonne Univ, Dept Pharmacol, Ctr Reg Pharmacovigilance Pitie St Antoine, AP HP, Paris, France
[2] CHU Montpellier, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale & Toxicol, Montpellier, France
[3] CHU Bordeaux, Ctr Reg Pharmacovigilance, Serv Pharmacol Medicale, Pole Sante Publ, Bordeaux, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷
关键词：
immune checkpoint inhibitors; peripheral neuropathy; pharmacovigilance;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-043
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors and Venous Thromboembolism: An Analysis of the WHO Pharmacovigilance Database
    Allouchery, Marion
    Beuvon, Clement
    Perault-Pochat, Marie-Christine
    Roblot, Pascal
    Puyade, Mathieu
    Martin, Mickael
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (01) : 164 - 170
  • [32] Hemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: A pharmacovigilance study from FDA Database
    Neupane, Niraj
    Shikhrakar, Shreeja
    Thapa, Sangharsha
    Shrestha, Asis
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
    Liu, Hao
    Li, Yumin
    Li, Jie
    Zhang, Qiongchi
    Wu, Jingtao
    Li, Xinyu
    Meng, Liesu
    Cao, Shuai
    Li, Haopeng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study
    Bastin, Marie
    Allouchery, Marion
    Sassier, Marion
    Rouby, Franck
    Eftekhari, Pirayeh
    Lebrun-Vignes, Benedicte
    Andreelli, Fabrizio
    Bihan, Kevin
    THERAPIE, 2021, 76 (06): : 695 - 703
  • [35] Nephrotoxicity in immune checkpoint inhibitor therapy: A pharmacovigilance study
    Haeuser, L.
    Marchese, M.
    Cone, E. B.
    Noldus, J.
    Bayliss, G.
    Kilbridge, K. L.
    Trinh, Q-D.
    EUROPEAN UROLOGY, 2021, 79 : S1361 - S1362
  • [36] NEPHROTOXICITY IN IMMUNE CHECKPOINT INHIBITOR THERAPY: A PHARMACOVIGILANCE STUDY
    Haeuser, Lorine
    Marchese, Maya
    Cone, Eugene B.
    Noldus, Joachim
    Bayliss, George
    Kilbridge, Kerry Laing
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2021, 206 : E261 - E262
  • [37] Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: A pharmacovigilance study
    Picca, Alberto
    Birzu, Cristina
    Berzero, Giulia
    Sanchez-Pena, Paola
    Gaboriau, Louise
    Vidil, Faustine
    Lenglet, Timothee
    Tafani, Camille
    Ricard, Damien
    Psimaras, Dimitri
    Bihan, Kevin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (11) : 4941 - 4949
  • [38] Nephrotoxicity of immune checkpoint inhibitor therapy: a pharmacovigilance study
    Haeuser, Lorine
    Marchese, Maya
    Cone, Eugene B.
    Noldus, Joachim
    Bayliss, George
    Kilbridge, Kerry Laing
    Quoc-Dien Trinh
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (07) : 1310 - 1316
  • [39] Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms
    Sarkar, Aritrani
    Nagappa, Madhu
    Dey, Saikat
    Mondal, Sandipan
    Babu, Gopika Suresh
    Choudhury, Saptamita Pal
    Akhil, Pokala
    Debnath, Monojit
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 (01) : 6 - 16
  • [40] Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study
    Wu, Junyan
    Huang, Jianxiang
    Zhu, Jianhong
    He, Zhichao
    Chen, Mengting
    Gao, Siyuan
    Liang, Dan
    Yu, Xiaoxia
    Lu, Chengyu
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 231 - 235
12345